This protocol covers paediatric patients under 18 years of age whose blood lead level (BLL) measures between 25 and 45 µg/dL — a range that requires careful clinical evaluation and, in certain circumstances, active pharmacological management.
When elevated blood lead levels persist despite environmental intervention, an oral chelation approach may be warranted. The full protocol specifies the precise conditions that trigger this step and the complete management pathway — partial details only are shown here.
The clinical aim is for symptoms to improve and for blood lead levels to reach an acceptable range.
At blood lead levels between 25 and 45 µg/dL, oral chelators may be of benefit if elevated blood levels persist following environmental intervention.
Once initiated, chelation therapy should be continued until symptoms improve and acceptable blood lead levels are achieved.
View source ↗